Bausch Health Cos - 6 Year Stock Price History | BHC

Historical daily share price chart and data for Bausch Health Cos since 2018 adjusted for splits and dividends. The latest closing stock price for Bausch Health Cos as of October 31, 2024 is 9.20.
  • The all-time high Bausch Health Cos stock closing price was 34.38 on March 11, 2021.
  • The Bausch Health Cos 52-week high stock price is 11.46, which is 24.6% above the current share price.
  • The Bausch Health Cos 52-week low stock price is 3.96, which is 57% below the current share price.
  • The average Bausch Health Cos stock price for the last 52 weeks is 7.61.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Bausch Health Cos Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 7.6824 7.7800 10.6100 5.2200 9.2000 14.71%
2023 7.8278 6.2800 9.8500 5.7200 8.0200 27.71%
2022 13.0150 27.7900 27.7900 4.5800 6.2800 -77.25%
2021 28.6747 21.3700 34.3800 21.3700 27.6100 32.74%
2020 19.3725 29.9100 30.2500 12.9800 20.8000 -30.48%
2019 24.1289 20.2300 31.8900 18.8900 29.9200 61.99%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.590B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00